Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07321600 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Resisted Inspiratory Muscle Training Applied in Addition to PSSE-Schroth Exercises

StatusRecruiting
PhaseNot applicable
Started2026-01-02
View on ClinicalTrials.gov ↗

Amendment history

2026-03-02
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Study sitesdetails revised at 1 of 1 site
2025-12-23
minor
Original filing
This prospective randomized controlled trial will evaluate whether adding resisted inspiratory muscle training (IMT) to Physiotherapeutic Scoliosis-Specific Exercises (PSSE)-Schroth exercises provides additional benefits on clinical outcomes in individuals with adolescent idiopathic scoliosis. Participants will be randomly assigned to either PSSE-Schroth plus IMT or PSSE-Schroth alone. Both groups will receive supervised exercise sessions three times per week for 8 weeks (24 sessions). Outcomes will be assessed before and after the intervention and will include clinical measures (e.g., Cobb angle, angle of trunk rotation, Posterior Trunk Symmetry Index, The Walter Reed Visual Assessment Scale), respiratory muscle performance (maximal inspiratory pressure/maximal expiratory pressure, six-minute walk test) and related physiological parameters, functional performance (balance, 3D kinematics, plantar pressure analysis, isokinetic strength), sleep quality, and health-related quality of life (Scoliosis Research Society- 22, Italian Spine Youth Quality of Life). The study is expected to enroll approximately 45 participants.
Trial Details
NCT Number NCT07321600
Lead Sponsor Hacettepe University
Collaborators: Kirsehir Ahi Evran Universitesi
Conditions Adolescence Idiopathic Scoliosis
Enrollment 45 participants
Start Date 2026-01-02
Primary Completion 2026-12-02 (estimated)
Study Completion 2027-03-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-03